Oruka Therapeutics (ORKA) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | -88.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.25% |
| Dec 31, 2025 | 87.31% |
| Sep 30, 2025 | -93.47% |
| Jun 30, 2025 | -44.76% |
| Mar 31, 2025 | -20.71% |
| Dec 31, 2024 | -32,977.65% |
| Sep 30, 2024 | 23,812.04% |
| Jun 30, 2024 | -1,718.73% |
| Mar 31, 2024 | 1,839.37% |
| Dec 31, 2023 | 29.32% |
| Sep 30, 2023 | 33.19% |
| Jun 30, 2023 | 73.53% |
| Mar 31, 2023 | 62.91% |
| Dec 31, 2022 | 69.84% |
| Sep 30, 2022 | 48.85% |
| Jun 30, 2022 | 29.82% |
| Mar 31, 2022 | -124.07% |
| Dec 31, 2021 | -144.76% |
| Sep 30, 2021 | -112.19% |
| Jun 30, 2021 | -257.51% |
| Mar 31, 2021 | 1,157.55% |
| Dec 31, 2020 | -57.88% |
| Sep 30, 2020 | 12,656.11% |
| Jun 30, 2020 | -153.32% |
| Mar 31, 2020 | -220.82% |
| Dec 31, 2019 | 11.46% |
| Sep 30, 2019 | 79.80% |
| Jun 30, 2019 | 179.64% |
| Mar 31, 2019 | -58.81% |
| Dec 31, 2018 | -358.57% |
| Sep 30, 2018 | -64.65% |
| Jun 30, 2018 | -183.96% |
| Mar 31, 2018 | 375.71% |
| Dec 31, 2017 | 180.69% |
| Sep 30, 2017 | 84.74% |
| Jun 30, 2017 | 119.11% |
| Mar 31, 2017 | 86.45% |
| Dec 31, 2016 | 74.10% |
| Sep 30, 2016 | -141.32% |
| Jun 30, 2016 | -148.08% |
| Mar 31, 2016 | -186.59% |
| Dec 31, 2015 | -41.42% |
| Sep 30, 2015 | -22.37% |
| Jun 30, 2015 | 1,852.86% |
| Mar 31, 2015 | -171.30% |
| Dec 31, 2014 | -1.01% |
| Sep 30, 2014 | -22.16% |
| Jun 30, 2014 | -110.81% |
| Mar 31, 2014 | 620.58% |
| Dec 31, 2013 | -1,058.02% |
| Sep 30, 2013 | -1,624.75% |
| Jun 30, 2013 | 1,712.74% |
| Mar 31, 2013 | 135.96% |
| Dec 31, 2012 | -183.08% |
| Sep 30, 2012 | 94.11% |
| Jun 30, 2012 | 50.45% |
| Mar 31, 2012 | 11.55% |
| Dec 31, 2011 | 122.13% |
| Sep 30, 2011 | 14.72% |